Supplementary Table 2.
Univariable and Multivariable Analysis on Factors Associated With Positive Serology to BNT162b2 mRNA Vaccine in LT Recipients and Health Care Workers (Controls) According to Antibody Titers After 3 Months From the 2-dose Vaccine (Dependent Variable: Positive Serology)
| Characteristics | Univariable, OR (95% CI) | P value | Multivariable, OR (95% CI) | P value |
|---|---|---|---|---|
| Age, y | ||||
| <40 | Ref | Ref | ||
| 40–65 | 0.07 (0.02–0.23) | < .00 | 0.16 (0.05–0.53) | .003 |
| >65 | 0.03 (0.00–0.09) | < .00 | 0.17 (0.05–0.58) | .005 |
| Male sex | 0.37 (0.24–0.58) | < .00 | 0.86 (0.53–1.39) | .55 |
| LT | 0.04 (0.02–0.08) | < .00 | 0.07 (0.03–0.13) | < .00 |
Note: Estimates were derived from multivariable logistic regression models adjusted for all the outcome variables.
Note: Boldface P values indicate statistical significance.
CI, Confidence interval; LT, liver transplant; OR, odds ratio.